N-[6-(3-oxopiperazin-1-yl)-3-pyridinyl]-2-pyrrolidin-2-ylacetamide

C15H21N5O2 — CID 119846046

IUPACN-[6-(3-oxopiperazin-1-yl)-3-pyridinyl]-2-pyrrolidin-2-ylacetamide
SMILESO=C1CN(c2ccc(NC(=O)CC3CCCN3)cn2)CCN1
InChIInChI=1S/C15H21N5O2/c21-14(8-11-2-1-5-16-11)19-12-3-4-13(18-9-12)20-7-6-17-15(22)10-20/h3-4,9,11,16H,1-2,5-8,10H2,(H,17,22)(H,19,21)
InChIKeyNUWHSRBPVRKGRJ-UHFFFAOYSA-N
MW303.37 g/mol
LogP0.10
Rot. Bonds4

About N-[6-(3-oxopiperazin-1-yl)-3-pyridinyl]-2-pyrrolidin-2-ylacetamide

N-[6-(3-oxopiperazin-1-yl)-3-pyridinyl]-2-pyrrolidin-2-ylacetamide (PubChem CID 119846046) has the molecular formula C15H21N5O2 and a molecular weight of 303.37 g/mol. Its IUPAC name is N-[6-(3-oxopiperazin-1-yl)-3-pyridinyl]-2-pyrrolidin-2-ylacetamide.

Molecular Properties

Compound NameN-[6-(3-oxopiperazin-1-yl)-3-pyridinyl]-2-pyrrolidin-2-ylacetamide
PubChem CID119846046
Molecular FormulaC15H21N5O2
Molecular Weight303.37 g/mol
Exact Mass303.17
IUPAC NameN-[6-(3-oxopiperazin-1-yl)-3-pyridinyl]-2-pyrrolidin-2-ylacetamide
SMILESO=C1CN(c2ccc(NC(=O)CC3CCCN3)cn2)CCN1
InChIInChI=1S/C15H21N5O2/c21-14(8-11-2-1-5-16-11)19-12-3-4-13(18-9-12)20-7-6-17-15(22)10-20/h3-4,9,11,16H,1-2,5-8,10H2,(H,17,22)(H,19,21)
InChIKeyNUWHSRBPVRKGRJ-UHFFFAOYSA-N
XLogP0.10
TPSA86.36 Ų
H-Bond Donors3
H-Bond Acceptors5
Rotatable Bonds4
Heavy Atoms22
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500303.37
LogP ≤ 50.10
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 105

Analyze N-[6-(3-oxopiperazin-1-yl)-3-pyridinyl]-2-pyrrolidin-2-ylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-[(1S)-cyclopent-2-en-1-yl]-N-[6-(3-oxopiperazin-1-yl)-3-pyridinyl]acetamide
CID 38940674
3-cyclopentylsulfonyl-N-[6-(3-oxopiperazin-1-yl)-3-pyridinyl]propanamide
CID 56795798
N-[6-(3-oxopiperazin-1-yl)-3-pyridinyl]-3-piperidin-4-ylbutanamide
CID 119846038
2-butylsulfanyl-N-[6-(3-oxopiperazin-1-yl)-3-pyridinyl]acetamide
CID 38939794
4-bromo-N-[6-(3-oxopiperazin-1-yl)-3-pyridinyl]benzamide
CID 38941033
1-benzyl-N-[6-(3-oxopiperazin-1-yl)-3-pyridinyl]pyrrolidine-2-carboxamide
CID 60579425
N-[6-(3-oxopiperazin-1-yl)-3-pyridinyl]pyridine-2-carboxamide
CID 38941036
N-[4-(2-oxoimidazolidin-1-yl)phenyl]-2-pyrrolidin-2-ylacetamide
CID 61365614
(3R)-N-[6-(3-oxopiperazin-1-yl)-3-pyridinyl]-3-(trifluoromethyl)piperidine-1-carboxamide
CID 51953423
2-(3-methoxyphenyl)-N-[6-(3-oxopiperazin-1-yl)-3-pyridinyl]acetamide
CID 34599898
4-bromo-2-chloro-N-[6-(3-oxopiperazin-1-yl)-3-pyridinyl]benzamide
CID 60511463
trans-(1R,2R)-2-(4-bromophenyl)-N-[6-(3-oxopiperazin-1-yl)-3-pyridinyl]cyclopropane-1-carboxamide
CID 97011933

Frequently Asked Questions

What is the IUPAC name of N-[6-(3-oxopiperazin-1-yl)-3-pyridinyl]-2-pyrrolidin-2-ylacetamide?
The IUPAC name of N-[6-(3-oxopiperazin-1-yl)-3-pyridinyl]-2-pyrrolidin-2-ylacetamide (CID 119846046) is N-[6-(3-oxopiperazin-1-yl)-3-pyridinyl]-2-pyrrolidin-2-ylacetamide.
What is the SMILES notation for N-[6-(3-oxopiperazin-1-yl)-3-pyridinyl]-2-pyrrolidin-2-ylacetamide?
The canonical SMILES for N-[6-(3-oxopiperazin-1-yl)-3-pyridinyl]-2-pyrrolidin-2-ylacetamide is O=C1CN(c2ccc(NC(=O)CC3CCCN3)cn2)CCN1.
What is the InChIKey of N-[6-(3-oxopiperazin-1-yl)-3-pyridinyl]-2-pyrrolidin-2-ylacetamide?
The InChIKey is NUWHSRBPVRKGRJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C15H21N5O2/c21-14(8-11-2-1-5-16-11)19-12-3-4-13(18-9-12)20-7-6-17-15(22)10-20/h3-4,9,11,16H,1-2,5-8,10H2,(H,17,22)(H,19,21).
What are the key properties of N-[6-(3-oxopiperazin-1-yl)-3-pyridinyl]-2-pyrrolidin-2-ylacetamide?
N-[6-(3-oxopiperazin-1-yl)-3-pyridinyl]-2-pyrrolidin-2-ylacetamide has a molecular weight of 303.37 g/mol, XLogP of 0.10, 4 rotatable bonds, 3 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for N-[6-(3-oxopiperazin-1-yl)-3-pyridinyl]-2-pyrrolidin-2-ylacetamide is sourced from PubChem (CID 119846046), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).